All Stories

  1. Utilizing Pharmacogenomic Data for a Safer Use of Statins among the Emirati Population

    Article • Current Vascular Pharmacology, January 2024, Bentham Science Publishers

    Zeina Almahayri

  2. Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations

    Article • Frontiers in Pharmacology, December 2023, Frontiers

    Zeina Almahayri

  3. The Utility of CYP2D6 and CYP2C19 Variants to Guide Pharmacological Treatment in Complex Unipolar Major Depression: A Pilot Longitudinal Study

    Article • Psychiatric Quarterly, July 2023, Springer Science + Business Media

    Zeina Almahayri

  4. Pharmacogenomics at the post-pandemic: If not now, then when?

    Article • Frontiers in Pharmacology, September 2022, Frontiers

    Zeina Almahayri

  5. Pharmacogenomics implementation in cardiovascular disease in a highly diverse population: initial findings and lessons learned from a pilot study in United Arab Emirates

    Article • Human Genomics, September 2022, Springer Science + Business Media

    Zeina Almahayri

  6. Mendelian randomization in pharmacogenomics: The unforeseen potentials

    Article • Biomedicine & Pharmacotherapy, June 2022, Elsevier

    Zeina Almahayri

  7. Long-Term Effects of Pediatric Acute Lymphoblastic Leukemia Chemotherapy: Can Recent Findings Inform Old Strategies?

    Article • Frontiers in Oncology, October 2021, Frontiers

    Zeina Almahayri

  8. Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide

    Article • Human Genetics, October 2021, Springer Science + Business Media

    Zeina Almahayri

  9. Current opinion on the pharmacogenomics of paclitaxel-induced toxicity

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2021, Taylor & Francis

    Zeina Almahayri

  10. Prevalence of pharmacogenomic variants in 100 pharmacogenes among Southeast Asian populations under the collaboration of the Southeast Asian Pharmacogenomics Research Network (SEAPharm)

    Article • Human Genome Variation, February 2021, Springer Science + Business Media

    Zeina Almahayri

  11. Variation in 100 relevant pharmacogenes among emiratis with insights from understudied populations

    Article • Scientific Reports, December 2020, Springer Science + Business Media

    Zeina Almahayri

  12. Association of variants inPTPN22,CTLA‐4,IL2‐RA, andINSgenes with type 1 diabetes in Emiratis

    Article • Annals of Human Genetics, September 2020, Wiley

    Zeina Almahayri

  13. Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy

    Article • Frontiers in Pharmacology, April 2020, Frontiers

    Zeina Almahayri

  14. VKORC1 variants as significant predictors of warfarin dose in Emiratis

    Article • Pharmacogenomics and Personalized Medicine, April 2019, Dove Medical Press

    George Patrinos, Zeina Almahayri

  15. Pharmacogenomics in pediatric acute lymphoblastic leukemia: promises and limitations

    Article • Pharmacogenomics, May 2017, Future Medicine

    Zeina Almahayri

  16. Genotype–phenotype spectrum of PYCR1-related autosomal recessive cutis laxa

    Article • Molecular Genetics and Metabolism, November 2013, Elsevier

    Zeina Almahayri

  17. High prevalence of genetic abnormalities in Middle Eastern patients with idiopathic non-obstructive azoospermia

    Article • Journal of Assisted Reproduction and Genetics, April 2013, Springer Science + Business Media

    Prof Marwan Alhalabi, Zeina Almahayri

  18. GJB2 gene mutations in Syrians with sensorineural hearing loss

    Article • Middle East Journal of Medical Genetics, July 2012, Egypts Presidential Specialized Council for Education and Scientific Research

    Zeina Almahayri

  19. A review of 1125 cases referred for cytogenetic analysis in Syria

    Article • Middle East Journal of Medical Genetics, January 2012, Egypts Presidential Specialized Council for Education and Scientific Research

    Zeina Almahayri